UTILITY OF SYNTHESIS REPERTORY IN THE HOMOEOPATHIC TREATMENT OF DANDRUFF

UTILITY OF SYNTHESIS REPERTORY IN THE HOMOEOPATHIC TREATMENT OF SEBORRHEIC DERMATITIS

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/03/032448

Enrollment

Registered

2021-03-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L21- Seborrheic dermatitis

Interventions

Intervention1: Individualized Homoeopathic medicine: Homoeopathic medicine will be selected through proper case taking and repertorization with the help of Synthetic Repertory. Control Intervention1:

Eligibility

Inclusion criteria

Inclusion criteria: a) Patients suffering from seborrheic dermatitis. b) Age between 10 -70 years c) Both sexes d) Patients willing to take part in the study and giving written consent.

Exclusion criteria

Exclusion criteria: a) Patients who are too sick for consultation. b) Diagnosed cases of unstable psychiatric illness or other systemic disease affecting quality of life. c) Pregnant and lactating women. d) Patients below 10 years of age are not included in the study as they are treated in the Pediatric department.

Design outcomes

Primary

Measure	Time frame
1)Seborrheic dermatitis Area and Severity Index (SASI) score 2)Dermatology Life Quality Index (DLQI) Timepoint: At the baseline and then after three months	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr BIRENDRA PRASAD SRIVASTAVA

National Institute of Homoeopathy, Department of Case taking and Repertory, OPD room no.-11

dr.srivastava61@gmail.com7003178867

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026